For example, myCAFs from pancreatic cancer release PGE2, which increases the expression of PD‐1, CTLA‐4, TIM‐3, and LAG‐3 on CD8+ T cells, thereby suppressing their antitumor functions [171]. This evidence concerns the gene CD8A and pancreatic neoplasm.